Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Abstract Text:

A R Gillams,W R Lees,A R Gillams,W R Lees,A R Gillams,W R Lees,

Secretin magnetic resonance cholangiopancreatography quantification (MRCPQ) of pancreatic exocrine function correlates well with steatorrhoea and conventional, non-invasive function tests. We report MRCPQ results in a variety of pancreatic conditions. A total of 215 patients [107 male, mean age 46 years (14-78)] were studied. A multi-slice MRCP sequence was performed before and at 2-min intervals after 0.1 ml/kg IV secretin. Change in small intestinal water volume was plotted against time and the flow rate derived from the gradient. Patients were classified using clinical history, MRCP, MR imaging, computed tomography (CT) [150/215 (70%)] and endoscopic retrograde cholangiopancreatography (ERCP) [56/215 (26%)] findings but not MRCPQ results. Mean, standard deviation and 95% confidence intervals were calculated. The one way ANOVA and Student's t-test were used for statistical analysis. Seventy-six patients had chronic pancreatitis, 26 were post-surgical, 34 post-acute pancreatitis, six atrophic pancreatopathy, eight with obstruction, 15 divisum, ten sphincter of Oddi dysfunction, 26 normal and 14 miscellaneous. Significant differences were observed between normals (mean+/-SD; 7.4 +/- 2.9 ml/min) and severe chronic pancreatitis (5.3 +/- 2.4) (P = 0.018), pancreatic atrophy (3.8 +/- 3.1) (P = 0.013) or duct obstruction (5.3 +/- 2.4) (P = 0.047)) and between moderate (7.0 +/- 3.0) (P = 0.03) and severe chronic pancreatitis. MRCPQ can be used to quantify function across the spectrum of pancreatic disease and showed significant differences between several different pathologies.

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Publishing Authors By Initials

AR Gillams,WR Lees,AR Gillams,WR Lees,AR Gillams,WR Lees,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European radiology

VOLUME: 17

Page Numbers: 2984-90

Journal Abbreviation:

ISSN: 0938-7994

DAY: 10

MONTH: 07

YEAR: 2007

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9114774

Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.

AFFILIATION: Department of Medical Imaging, University College London Medical School and University College London Hospitals, London, UK. a.gillams@medphys.ucl.ac.ak

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur Radiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Quantitative secretin MRCP MRCPQ: results in 215 patients with known or suspected pancreatic pathology Related Publications

• A new method of applying the screen test for inter-ocular muscle balance.
• A statistical and clinical review of 107 cases of ectopic gestation.
• Acute stroke: we have the treatments and we have the evidence--we need to use them.
• Advances in emerging therapies 2007.
• Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
• DIAGNOSIS OF DIPLOPIA.
• Effects of the Occupational Safety and Health Administration's control of hazardous energy (lockout/tagout) standard on rates of machinery-related fatal occupational injury.
• FoxO3a preferentially induces p27(Kip1) expression while impairing muscle precursor cell-cycle progression.
• Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products.
• Issues pertaining to the critiques of the SAINT-I Trial.
• Life and death decisions by the E2F transcription factors.
• Modern concepts of instinctive behaviour.
• Parkinson's disease with Onuf's nucleus involvement mimicking multiple system atrophy.
• Prediction and perinatal outcomes of fetal growth restriction.
• Prevention of atherosclerosis progression in asymptomatic healthy elderly.
• Punding in Parkinson's disease.
• Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology.
• RECTAL NARCOSIS IN OPHTHALMIC SURGERY.
• Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
• SYNTHESIS OF UNSATURATED FATTY ACIDS IN THE SLIME MOLD PHYSARUM POLYCEPHALUM AND THE ZOOFLAGELLATES LEISHMANIA TARENTOLAE, TRYPANOSOMA LEWISI, AND CRITHIDIA SP.: A COMPARATIVE STUDY.
• Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues.
• THE USE OF UNIT CELLS IN THE LISTER MORTON OPHTHALMOSCOPE.
• The effects of intravenous hyperalimentation on plasma proteins in severe hypercholesterolemia [proceedings].
• The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
• The teaching of venereology.
• Time spent at home poststroke: "home-time" a meaningful and robust outcome measure for stroke trials.
• Tuberculosis among medical and academic students.
• Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.
• WITHDRAWN: Institutional versus at-home long term care for functionally dependent older people.
• catena-Poly[[bis(nitrato-kappa(2)O,O')copper(II)]-mu-propane-1,3-diylbis(diphenylphosphine oxide)-kappa(2)O:O'].